Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Cain

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Exceptional Children|May 1, 1976
Parent groups: their role in a better life for the handicappedL F Cain
The New Zealand Medical Journal|July 1, 1970
Experimental leukaemia chemotherapy: a perspectiveB F Cain
The New Zealand Medical Journal|November 10, 1976
Cancer chemotherapy: drug combination and multiple modality treatmentB F Cain
Cancer Chemotherapy Reports|July 1, 1975
Commentary. The role of structure-activity studies in the design of antitumor agentsB F Cain
American Heart Journal|March 19, 2010
Wolff-Parkinson-White syndrome presenting certain unusual featuresE F CAIN
The New Zealand Medical Journal|February 1, 1971
Experimental cancer chemotherapy: strategy for cureB F Cain
Dalton Transactions (Cambridge, England : 2003)|June 16, 2026
Transition metal-type reactivity at trivalent P-centers: how structural distortions promote bond breaking and forming <i>via</i> two-electron redox reactions and/or phosphorus-ligand cooperativityMatthew F Cain
Journal of Medicinal Chemistry|September 1, 1976
Potential antitumor agents. 19. Multiply substituted 4'-(9-acridinylamino)methanesulfonanilidesB F Cain, G Atwell
Journal of Medicinal Chemistry|May 1, 1978
Potential antitumor agents. 27. Quantitative structure--antileukemic (L1210) activity relationships for the omega-[4-(9-acridinylamino)phenyl]alkanoic acidsW A Denny, B F Cain
Journal of Medicinal Chemistry|December 1, 1976
Potential antitumor agents. 20. Structure-activity-site relationships for the 4'(9-acridinylamino)alkanesulfonanilidesB F Cain, G J Atwell
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Exceptional Children|May 1, 1976
Parent groups: their role in a better life for the handicappedL F Cain
The New Zealand Medical Journal|July 1, 1970
Experimental leukaemia chemotherapy: a perspectiveB F Cain
The New Zealand Medical Journal|November 10, 1976
Cancer chemotherapy: drug combination and multiple modality treatmentB F Cain
Cancer Chemotherapy Reports|July 1, 1975
Commentary. The role of structure-activity studies in the design of antitumor agentsB F Cain
American Heart Journal|March 19, 2010
Wolff-Parkinson-White syndrome presenting certain unusual featuresE F CAIN
The New Zealand Medical Journal|February 1, 1971
Experimental cancer chemotherapy: strategy for cureB F Cain
Dalton Transactions (Cambridge, England : 2003)|June 16, 2026
Transition metal-type reactivity at trivalent P-centers: how structural distortions promote bond breaking and forming <i>via</i> two-electron redox reactions and/or phosphorus-ligand cooperativityMatthew F Cain
Journal of Medicinal Chemistry|September 1, 1976
Potential antitumor agents. 19. Multiply substituted 4'-(9-acridinylamino)methanesulfonanilidesB F Cain, G Atwell
Journal of Medicinal Chemistry|May 1, 1978
Potential antitumor agents. 27. Quantitative structure--antileukemic (L1210) activity relationships for the omega-[4-(9-acridinylamino)phenyl]alkanoic acidsW A Denny, B F Cain
Journal of Medicinal Chemistry|December 1, 1976
Potential antitumor agents. 20. Structure-activity-site relationships for the 4'(9-acridinylamino)alkanesulfonanilidesB F Cain, G J Atwell
Pageof 9